Balancing act required when considering ESAs for cancer-related anaemia

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1251, 2009-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epoetin alfa improves QOL in cancer-related anaemia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 251, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Epoetin alfa improves QOL in cancer-related anaemia

Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Role of Erythropoietin in Cancer-related Anaemia: a Double-edged Sword?

By Guan X Chen L

The Journal of International Medical Research, Vol. 36, Iss. 1, 2008-01 ,pp. : 1-8

Field House Publishing

Access to resources Recommend Favorite

Symptomatic treatment of cancer-related anaemia involves blood transfusions and/or erythropoietic agents

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 22, Iss. 5, 2006-05 ,pp. : 7-10

Adis International

Access to resources Recommend Favorite

Management of cancer-related fatigue

Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite